kr
26.40
Oct 30
New Key Statistics Module, Z-Score and F-Score
XSAT:GENE Key Ratios
Market Cap kr M | 262.92 |
Enterprise Value kr M | 171.79 |
P/E(ttm) | 26.14 |
PE Ratio without NRI | 26.14 |
Forward PE Ratio | -- |
Price/Book | 1.72 |
Price/Sales | 3.50 |
Price/Free Cash Flow | 23.55 |
Price/Owner Earnings | 94.96 |
Payout Ratio % | -- |
Revenue (TTM) kr M | 75.00 |
EPS (TTM) kr | 1.01 |
Beneish M-Score | -2.34 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -5.80 |
EV-to-EBIT | 12.82 |
EV-to-EBITDA | 10.19 |
PEG | -- |
Shares Outstanding M | 9.96 |
Net Margin (%) | 13.45 |
Operating Margin % | 15.22 |
Pre-tax Margin (%) | 17.70 |
Quick Ratio | 7.99 |
Current Ratio | 8.09 |
ROA % (ttm) | 6.25 |
ROE % (ttm) | 6.88 |
ROIC % (ttm) | 11.83 |
Dividend Yield % | -- |
Altman Z-Score | 11.68 |
XSAT:GENE Number of Guru Trades
XSAT:GENE Volume of Guru Trades
Gurus Latest Trades with XSAT:GENE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
XSAT:GENE is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data